Clomipramine recalls

The FDA has published 8 recalls involving Clomipramine since 2014. The latest was reported on 12 Nov 2025. Most were for potency & assay. Zydus Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls8since 2014
Last 12 months3reported
Class I00% of total
Ongoing3latest 12 Nov 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 7 88%Class III 1 13%

Why clomipramine is recalled

By year

Ongoing clomipramine recalls

3 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIclomiPRAMINE Hydrochloride, Capsules, USP, 75 mg recalledClomipramine HydrochlorideZydus PharmaceuticalsNitrosamine ImpurityNationwide
DrugCLASS IIclomiPRAMINE Hydrochloride, Capsules, USP, 50 mg recalledClomipramine HydrochlorideZydus PharmaceuticalsNitrosamine ImpurityNationwide
DrugCLASS IIclomiPRAMINE Hydrochloride, Capsules, USP, 25 mg recalledClomipramine HydrochlorideZydus PharmaceuticalsNitrosamine ImpurityNationwide

All clomipramine recalls, newest first

8 total

Should you stop taking Clomipramine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.